Plexus Stock Forecast, Price & News

Plexus' stock was trading at $60.68 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PLXS stock has increased by 17.2% and is now trading at $71.12.
View which stocks have been most impacted by COVID-19.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Plexus in the last year. There are currently 3 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Plexus.

Plexus is scheduled to release its next quarterly earnings announcement on Wednesday, October 28th 2020.
View our earnings forecast for Plexus.

Plexus Corp. (NASDAQ:PLXS) posted its quarterly earnings data on Wednesday, July, 22nd. The technology company reported $1.20 EPS for the quarter, beating the Zacks' consensus estimate of $0.75 by $0.45. The technology company earned $857.39 million during the quarter, compared to the consensus estimate of $801.94 million. Plexus had a net margin of 3.55% and a return on equity of 12.41%.
View Plexus' earnings history.

Plexus updated its fourth quarter earnings guidance on Wednesday, July, 22nd. The company provided earnings per share guidance of $1.05 to $1.20 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.90. The company issued revenue guidance of $850 million to $890 million, compared to the consensus revenue estimate of $820.47 million.

6 brokers have issued 12 month price objectives for Plexus' stock. Their forecasts range from $78.00 to $91.00. On average, they anticipate Plexus' stock price to reach $82.80 in the next twelve months. This suggests a possible upside of 16.4% from the stock's current price.
View analysts' price targets for Plexus.

Plexus saw a drop in short interest during the month of August. As of August 14th, there was short interest totaling 849,300 shares, a drop of 15.1% from the July 30th total of 1,000,000 shares. Based on an average daily trading volume, of 216,000 shares, the days-to-cover ratio is presently 3.9 days. Approximately 3.0% of the shares of the stock are sold short.
View Plexus' Short Interest.

Some companies that are related to Plexus include Trimble (TRMB), IPG Photonics (IPGP), Jabil (JBL), Mercury Systems (MRCY), Fabrinet (FN), Sanmina (SANM), TTM Technologies (TTMI), Methode Electronics (MEI), Benchmark Electronics (BHE), CTS (CTS), Park Electrochemical (PKE), Key Tronic (KTCC) and Neonode (NEON).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Plexus investors own include Bristol-Myers Squibb (BMY), Walgreens Boots Alliance (WBA), Pfizer (PFE), Cisco Systems (CSCO), Gilead Sciences (GILD), Intel (INTC), QUALCOMM (QCOM), Twitter (TWTR), Berry Global Group (BERY) and ConocoPhillips (COP).

Plexus trades on the NASDAQ under the ticker symbol "PLXS."

Plexus' stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (10.45%), Victory Capital Management Inc. (3.66%), Silvercrest Asset Management Group LLC (2.86%), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (2.41%), Fisher Asset Management LLC (1.97%) and Thrivent Financial for Lutherans (1.42%). Company insiders that own Plexus stock include Angelo Michael Ninivaggi Jr, David J Drury, Dean A Foate, Michael V Schrock, Patrick John Jermain, Peter Kelly, Ralf R Boer, Ronnie Darroch, Scott Theune, Stephen P Cortinovis, Steven J Frisch, Todd P Kelsey and Yong Jin Lim.
View institutional ownership trends for Plexus.

PLXS stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Vanguard Group Inc., Grantham Mayo Van Otterloo & Co. LLC, Charles Schwab Investment Management Inc., WINTON GROUP Ltd, Nuveen Asset Management LLC, Prudential Financial Inc., and Balyasny Asset Management LLC. Company insiders that have sold Plexus company stock in the last year include Angelo Michael Ninivaggi Jr, David J Drury, Dean A Foate, Michael V Schrock, Patrick John Jermain, Ronnie Darroch, Stephen P Cortinovis, Steven J Frisch, Todd P Kelsey, and Yong Jin Lim.
View insider buying and selling activity for Plexus.

PLXS stock was bought by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., New York State Common Retirement Fund, BNP PARIBAS ASSET MANAGEMENT Holding S.A., Assenagon Asset Management S.A., Channing Capital Management LLC, Thrivent Financial for Lutherans, Meritage Portfolio Management, and Intrinsic Edge Capital Management LLC.
View insider buying and selling activity for Plexus.

Shares of PLXS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PLXS stock can currently be purchased for approximately $71.12.

Plexus has a market capitalization of $2.08 billion and generates $3.16 billion in revenue each year. The technology company earns $108.62 million in net income (profit) each year or $3.43 on an earnings per share basis. Plexus employs 19,000 workers across the globe.

The official website for Plexus is www.plexus.com.

Plexus' mailing address is One Plexus Way, Neenah WI, 54957. The technology company can be reached via phone at 920-969-6000 or via email at [email protected]